Yuxian Bai - Harbin Medical University Cancer Hospital

基本信息

Career Trajectory

Bio

白玉贤，女，主任医师、教授、中共党员，现担任中国抗癌协会胃癌专业委员会委员、中国抗癌协会临床肿瘤学中心（CSCO）执行委员会委员、黑龙江省抗癌协会胃癌专业委员会副主任委员、黑龙江省女医师协会理事，哈尔滨医科大学第三临床医学院内二科主任，内科党支部书记，硕士生导师。

Research Interests

Papers共 434 篇Author StatisticsCo-AuthorSimilar Experts

By YearBy Citation主题筛选期刊级别筛选合作者筛选合作机构筛选

First-line Treatment of Anti-Egfr Monoclonal Antibody Cetuximab Β Plus FOLFIRI Versus FOLFIRI Alone in Chinese Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer: a Randomized, Phase 3 Trial

Yuankai Shi,Yi Ba,Junye Wang,Jianping Xiong,Kangsheng Gu,Yigui Chen,Zhendong Zheng,Zishu Wang,Weijian Guo,Ying Cheng,Xianli Yin,Yunpeng Liu,Yuxian Bai,Enxiao Li,Qi Li,Liangjun Zhu,Wei Li,Da Jiang, Jingdong He,Jiansi Chen, Jianguo Sun, Sheng Hou

Signal transduction and targeted therapyno. 1 (2025): 147-147

Cited0Views0WOSNATUREBibtex

Lenvatinib Plus Pembrolizumab and Chemotherapy Versus Chemotherapy in Advanced Metastatic Gastroesophageal Adenocarcinoma: the Phase III, Randomized LEAP-015 Study

Kohei Shitara,Sylvie Lorenzen,Jin Li,Yuxian Bai, Manuel González Fernández, Mynor Aguilar,Hirokazu Shoji, Felipe Reyes-Cosmelli, Yovany Rodriguez Peña, Luis Corrales,Lucjan Wyrwicz, Daniel Acosta Eyzaguirre,Yueyin Pan,Min-Hee Ryu, Deirdre J Cohen, Zev A Wainberg, Geoffrey Ku,Josep Tabernero,Eric Van Cutsem,Shu-Kui Qin, Do-Youn Oh,Jianming Xu, Li Wen Liang, Sonal Bordia, Pooja Bhagia,Sun Young Rha, LEAP-01 Investigators

Journal of clinical oncology official journal of the American Society of Clinical Oncologypp.JCO2500748-JCO2500748, (2025)

Cited0Views0WOSBibtex

Paclitaxel Oral Solution Versus Paclitaxel Injection As a Second-Line Therapy in Advanced Gastric Cancer: A Randomized, Open-Label, Non-Inferiority Phase 3 Trial

Jin Li,Mingzhu Huang,Ting Deng,Yuxian Bai,Tianshu Liu,Yueyin Pan,Junyan Yu,Hongming Pan,Huiting Xu,Jufeng Wang,Feng Ye,Junye Wang,Jinsheng Wu,Shundong Cang,Kehe Chen, Jun Zhang,Jingdong Zhang,Yang Ling, Yin Liu,Shukui Qin

Journal of Clinical Oncologyno. 4_suppl (2025): 442-442

Cited0Views0Bibtex

Toripalimab Plus Bevacizumab Versus Sorafenib As First-Line Treatment for Advanced Hepatocellular Carcinoma (HEPATORCH): a Randomised, Open-Label, Phase 3 Trial

Yinghong Shi,Guohong Han,Jian Zhou,Xuetao Shi,Weidong Jia,Ying Cheng, Yongdong Jin, Xiangdong Hua,Tianfu Wen,Jianbing Wu,Shanzhi Gu,Yuxian Bai,Xiangcai Wang,Tao Zhang,Zhiyu Chen,Bixiang Zhang, Ming Huang,Hongming Liu,Yilei Mao,Ledu Zhou, Rui Wang,Yunfeng Shan,Wu Zhang,Tianqiang Song,Yabing Guo,Fuxiang Zhou,Bingfeng Shao,Mingjun Zhang, Bo Liang,Jinfang Zheng, Guoping Zhang,Jie Shen,Weiwen Su, Feng Zhang,Yifu He,Sheng Hu,Rong Liu,Chengwu Zhang,Shunli Shen,Hui Zeng, Tsang-En Wang,Wenzhi Guo,Yan Shen,Yajin Chen,Yong Li, J Samol,Hongtao Hu, Wenhua Zhang,Chengyou Du,Enxiao Li,Chao Liu,Choo Su Pin,Xun Li,Hao Xu, Jee-Fu Huang,Chunyi Hao,Jing Lv, Wei Wang, Qian Xu, Aobing Bai,Xiao Zhang, Bifeng Liu, Chunlei Jin,Jia Fan

The lancet Gastroenterology & hepatologyno. 7 (2025): 658-670

Cited0Views0WOSBibtex

First-Line Pembrolizumab Plus Chemotherapy for HER2-Negative Advanced Gastric Cancer: China Subgroup Analysis of the Randomized Phase 3 KEYNOTE-859 Study

Shukui Qin,Yuxian Bai,Jin Li,Hongming Pan,Suxia Luo, Yanli Qu,Feng Ye,Lin Yang,Tianshu Liu,Wei Li,Xi Chen, Jianwei Yang,Jieer Ying,Xiaoyan Lin,Lin Zhao,Xinjun Liang,Yixiang Mao, Run Guo, Yi Zuo, Sonal Bordia, Shouguo Li

Advances in Therapyno. 4 (2025): 1892-1906

Cited0Views0WOSBibtex

Pembrolizumab or Placebo Plus Chemotherapy for Advanced HER2-negative Gastric or Gastroesophageal Junction (G/GEJ) Adenocarcinoma: an Updated Analysis of KEYNOTE-859 for Patients Enrolled in Asia

Chia Jui Yen,Do-Youn Oh,Yuxian Bai,Min-Hee Ryu,Jeeyun Lee,Jin Li,Lin Yang,Hisateru Yasui,Hiroshi Yabusaki,Ka On Lam,Kensei Yamaguchi,Kun-Huei Yeh, Lina Yin,Pierre Leconte,Pooja Bhagia,Sun Young Rha

Journal of Clinical Oncologyno. 4_suppl (2025): 464-464

Cited0Views0Bibtex

Tislelizumab Plus Chemotherapy Versus Placebo Plus Chemotherapy As First-Line Treatment of Advanced Gastric or Gastroesophageal Junction Adenocarcinoma: Patient-Reported Outcomes in the RATIONALE-305 Study

Marcia Cruz-Correa,Rui-Hua Xu,Markus Moehler, Do-Youn Oh,Ken Kato,David Spigel, Hendrik-Tobias Arkenau,Josep Tabernero, Anastasia V Zimina,Yuxian Bai,Jianhua Shi,Keun-Wook Lee,Hidekazu Hirano,Lucjan Wyrwicz, Roberto Pazo Cid, Hui Xu, Tao Sheng, Gisoo Barnes

Current medical research and opinionpp.1-10, (2025)

Cited0Views0WOSBibtex

Anlotinib Plus Penpulimab Versus Sorafenib in the First-Line Treatment of Unresectable Hepatocellular Carcinoma (APOLLO): a Randomised, Controlled, Phase 3 Trial

Jian Zhou,Li Bai,Jia Luo,Yuxian Bai,Yaozhen Pan,Xinrong Yang, Yufeng Gao,Rongshu Shi, Wenhua Zhang,Jinfang Zheng, Xiangdong Hua, Aibing Xu,Sheng Hu, Feng Zhang, Xiaojun Yang,Mingxu Da, Rui Wang,Jie Ma,Weidong Jia,Dongmei Quan,Chuang Peng, Wei Yang,Guowen Yin, Yue Qi, Guifang Zhang,Xilin Du,Xiaorong Mao,Zhiqiang Meng,Shunchang Jiao,Jia Fan, APOLLO Study Group

The Lancet Oncologyno. 6 (2025): 719-731

Cited0Views0WOSBibtex

Author Statistics

Co-Author

Co-Institution

D-Core

合作者
学生
导师

No result temporarily, you can search similar Scholar with the same research interest

Data Disclaimer

The page data are from open Internet sources, cooperative publishers and automatic analysis results through AI technology. We do not make any commitments and guarantees for the validity, accuracy, correctness, reliability, completeness and timeliness of the page data. If you have any questions, please contact us by email: report@aminer.cn

Yuxian Bai(白玉贤)

主任医师

Papers共 434 篇Author StatisticsCo-AuthorSimilar Experts